GShC-Net: Hybrid deep learning with DCTLAP feature extraction for brain tumor detection.

Comput Biol Chem

Department of Electronics and Communication Engineering, Prathyusha Engineering College (Autonomous), Tamil Nadu, India. Electronic address:

Published: December 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

A brain tumor is an abnormal cell growth in a brain, which is not detected early. Initial detection of brain tumors is extremely critical for treatment planning as well as the survival of a patient. Brain tumors come in different forms, have unique properties, and require tailored therapies. Thus, detecting brain tumors physically is a laborious, complex, as well as error-prone process. Hence, an automated computer-assisted diagnosis with better correctness is presently in high demand. Here, this paper developed a hybrid GoogleNet-Shepard Convolutional Networks (GShC-Net) method that is employed for detecting brain tumors. The process of this approach is as illustrated follows. Firstly, an input image is carried out from the database that is given to a pre-processing module. After that, brain tumor segmentation is performed, as well as features such as Haralick texture features, Statistical features, and Discrete Cosine Transform with Local Arc Pattern (DCTLAP) are extracted. Finally, brain tumor is detected based on GShC-Net. Moreover, the GoogleNet and Shepard Convolutional Neural Networks (ShCNN) models are fused to create GShC-Net, in which the layers are modified. The proposed GShC-Net method effectively improves the early detection and classification of brain tumors, potentially aiding in more accurate and timely medical diagnoses. Furthermore, the GShC-Net is assessed by using True Positive Rate (TPR), True Negative Rate (TNR), as well as accuracy and the values attained are0.940, 0.930, and 0.932, respectively.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.compbiolchem.2025.108577DOI Listing

Publication Analysis

Top Keywords

brain tumors
20
brain tumor
16
brain
10
detection brain
8
detecting brain
8
gshc-net method
8
gshc-net
6
tumors
5
gshc-net hybrid
4
hybrid deep
4

Similar Publications

Central nervous system (CNS) diseases, including neurodegenerative diseases, stroke, brain tumors, and others, result in poor quality of life and can cause substantial disability. Not all CNS diseases are amenable to surgical approaches, so drug development is important for disease treatment. Unfortunately, there are few drugs currently available for CNS diseases.

View Article and Find Full Text PDF

Utility and performance of cerebrospinal fluid cytology in discriminating central nervous system infections and brain tumors.

J Neurooncol

September 2025

Department of Neurology, Xiangya Hospital, Central South University, No.87 Xiangya Road, Kaifu District, Changsha, 410008, Hunan Province, China.

Background And Objective: Differentiating central nervous system infections (CNSIs) from brain tumors (BTs) is difficult due to overlapping features and the limited individual indicators, and cerebrospinal fluid (CSF) cytology remains underutilized. To improve differential diagnosis, we developed a model based on 9 early, cost-effective cerebrospinal fluid parameters, including CSF cytology.

Methods: Patients diagnosed with CNSIs or BTs at Xiangya Hospital of Central South University between October 1st, 2017 and March 31st, 2024 were enrolled and divided into the training set and the test set.

View Article and Find Full Text PDF

Causes of Death After Surgery Among Cancer Patients: A Population-based Cohort Study.

Int J Surg

September 2025

State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.

Introduction: Recent advancements in surgical techniques and perioperative care have improved cancer survival rates, yet postoperative comorbidity and mortality remain a critical concern. Despite progress in cancer control, systematic analyses of long-term mortality trends and competing risks in surgery-intervened cancer populations are lacking. This study aimed to quantify temporal patterns of postoperative mortality causes across 21 solid cancers and identify dominant non-cancer risk factors to inform survivorship care strategies.

View Article and Find Full Text PDF

Aim    Search for subclinical manifestations of cardiotoxicity in cancer patients at high and very high risk of cardiotoxicity and evaluation of the effectiveness of drug primary prevention during the antitumor treatment. Material and methods    The study included 150 cancer patients with a high and very high Mayo Clinic (USA) Cardiotoxicity Risk Score. The main group consisted of 84 patients at high and very high risk of cardiotoxicity who were prescribed cardioprotective therapy, including a fixed combination of the angiotensin-converting enzyme inhibitor (ACEI) perindopril and the beta-blocker bisoprolol with trimetazidine.

View Article and Find Full Text PDF